Literature DB >> 4340925

Isoprinosine: lack of antiviral activity in experimental model infections.

L A Glasgow, G J Galasso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4340925      PMCID: PMC7110087          DOI: 10.1093/infdis/126.2.162

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Evaluation of isoprinosine in experimental human rhinovirus infection.

Authors:  D M Pachuta; Y Togo; R B Hornick; A R Schwartz; S Tominaga
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

Review 2.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

3.  Anti-herpesvirus action of isoprinosine.

Authors:  P Gordon; B Ronsen; E R Brown
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

4.  Plaque inhibition assay for drug susceptibility testing of influenza viruses.

Authors:  F G Hayden; K M Cote; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

5.  Effect of isoprinosine against challenge with A(H3N2)-Hong Kong influenza virus in volunteers.

Authors:  S Longley; R L Dunning; R H Waldman
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

Review 6.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

7.  Inhibition of Rabies Virus by 1,2,3,4,6-Penta-O-galloyl-β-d-Glucose Involves mTOR-Dependent Autophagy.

Authors:  Zhongzhong Tu; Wenjie Gong; Yan Zhang; Ye Feng; Yan Liu; Changchun Tu
Journal:  Viruses       Date:  2018-04-17       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.